Risk of Onset of Second Neoplasms and Successive Neoplasms in Patients with a Head and Neck Index Tumour
Overview
Affiliations
Objective: To analyse the incidence of appearance of second and successive neoplasms in a cohort of head and neck squamous carcinoma patients.
Material And Methods: We conducted a retrospective study with 4,458 patients with an index tumour located in the head and neck diagnosed during the 1985-2016 period. We evaluated the incidence of appearance of second neoplasms and successive neoplasms over a period of 30 years.
Results: During the follow-up, 1,203 patients (27.0%) had a second neoplasm, 242 patients (5.4%) a third neoplasm, 58 patients (1.3%) a fourth neoplasm, and 8 patients (0.2%) 5 or more successive neoplasms. The incidence of appearance of second neoplasms was 3.5% per year, remaining relatively constant throughout the follow-up period. The patients with a second neoplasm had a higher risk of appearance of a third neoplasm, and those with a third neoplasm had a higher risk of a fourth. Seventy-eight percent of the second neoplasms, 88% of the third neoplasms, and 89.6% of the fourth neoplasms appeared in locations epidemiologically related to tobacco and alcohol use.
Conclusions: Second neoplasms after a head and neck index tumour appeared at a constant rate of 3.5% per year throughout the entire follow-up period.
An Overview of Head and Neck Tumor Reirradiation: What Has Been Achieved So Far?.
Gordon K, Smyk D, Gulidov I, Golubev K, Fatkhudinov T Cancers (Basel). 2023; 15(17).
PMID: 37686685 PMC: 10486419. DOI: 10.3390/cancers15174409.
Dzaman K, Czerwaty K Pharmaceutics. 2023; 15(5).
PMID: 37242569 PMC: 10223025. DOI: 10.3390/pharmaceutics15051327.
Factors associated with the development of second primary tumours in head and neck cancer patients.
Salcedo-Bellido I, Requena P, Mateos R, Ortega-Rico C, Olmedo-Requena R, Lozano-Lorca M Eur J Cancer Care (Engl). 2022; 31(6):e13699.
PMID: 36117311 PMC: 9787413. DOI: 10.1111/ecc.13699.
Factors associated with loss to follow-up after radiation therapy for head and neck cancer.
Hoyle J, Correya T, Kenzik K, Francisco L, Spencer S, Willey C Head Neck. 2022; 44(4):943-951.
PMID: 35080075 PMC: 8904314. DOI: 10.1002/hed.26986.
Causes of long-term mortality in patients with head and neck squamous cell carcinomas.
Lop J, Venegas M, Pujol A, Sauter B, Vasquez R, Casasayas M Eur Arch Otorhinolaryngol. 2021; 279(7):3657-3664.
PMID: 34905065 PMC: 9130168. DOI: 10.1007/s00405-021-07211-8.